| Financial Year |
September 30 2021 |
| Monetary Funds |
3,379,091,082.37 |
| Held-for-trading Financial Assets |
1,075,449,842.36 |
| Notes Receivable |
-- |
| Accounts Receivable |
35,775,922.55 |
| Advances to Suppliers |
8,872,158.19 |
| Other Receivables |
22,578,470.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
595,109,077.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,969,621.54 |
| Total Current Assets |
5,354,657,027.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
307,539,972.22 |
| Investment Properties |
28,532,403.09 |
| Fixed Assetes |
662,383,847.44 |
| Under-construction Projects |
3,722,159.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
310,066,631.99 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
68,196,151.03 |
| Deferred Income Tax Assets |
119,990,505.22 |
| Other Non-Current Assets |
63,753,057.41 |
| Sub-Total of Non-Current Assets |
2,766,495,812.88 |
| Total Assets |
8,121,152,839.96 |
| Short-Term Loans |
197,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
754,867,583.05 |
| Accounts Received In Advance |
28,646,333.57 |
| Employee Compensation Payable |
45,576,430.78 |
| Taxes Payable |
54,121,586.37 |
| Interest Payable |
-- |
| Dividend Payable |
956,374.50 |
| Other payables |
1,032,847,366.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
436,180,839.14 |
| Other Current Liabilities |
7,772,716.20 |
| Sub-Total of Current Liabilities |
2,638,617,546.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
29,693,737.89 |
| Deferred Income Tax Liabilities |
1,362,460.59 |
| Other Non-Current Liabilities |
20,409,590.88 |
| Sub-Total of Non-Current Liabilities |
1,147,424,549.64 |
| Total Liabilities |
3,786,042,096.41 |
| Paid-In Capital(Or Share Stock) |
658,407,554.00 |
| Capital Surplus |
825,044,871.93 |
| Surplus Reserve |
360,907,796.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,243,648,208.94 |
| Minority Stockholder's Interest |
247,102,311.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,088,008,431.56 |
| Owner's Equity（Stockholder's Equity） |
4,335,110,743.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,121,152,839.96 |
